Range Capital Acquisition Corp.
For the period ended Dec 31, 2025. Filed Mar 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 25, 2026
RANG$10.930.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2025 and 2024
BALANCE SHEETS
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash | $313,322 | $881,853 |
| Prepaid expenses | 103,995 | 128,720 |
| Total Current assets | 417,317 | 1,010,573 |
| Long-term prepaid insurance | — | 100,054 |
| Investments held in Trust Account | 120,509,940 | 100,596,478 |
| Total Assets | $120,927,257 | $101,707,105 |
| Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Equity | ||
| Current liabilities | ||
| Accrued offering costs | $75,000 | $75,000 |
| Accounts payable and accrued expenses | 131,622 | 41,117 |
| Over-allotment option liability | — | 147,970 |
| Total Liabilities | 206,622 | 264,087 |
| Commitments And Contingencies (Note 6) | ||
| Ordinary shares subject to possible redemption, 11,500,000 and 10,000,000 shares at redemption value of approximately $10.48 and $10.06 per share as of December 31, 2025 and 2024, respectively | 120,509,940 | 100,596,478 |
| Shareholders’ Equity | ||
| Preference shares, $0.0001 par value; 100,000,000 shares authorized; none issued and outstanding | — | — |
| Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,537,500 and 4,500,000 issued and outstanding (excluding 11,500,000 and 10,000,000 subject to possible redemption) as of December 31, 2025 and 2024, respectively (1)(2) | 454 | 450 |
| Additional paid-in capital | — | 885,564 |
| Retained Earnings (Accumulated deficit) | 210,241 | (39,474) |
| Total Shareholders’ Equity | 210,695 | 846,540 |
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Equity | $120,927,257 | $101,707,105 |
| (1) | December 31, 2024 includes an aggregate of up to 500,000 ordinary shares subject to forfeiture if the over-allotment was not exercised in full or in part by the underwriters (See Notes 5 and 7). |
| (2) | On January 3, 2025, the underwriters fully exercised their over-allotment option resulting in no shares subject to forfeiture related to the over-allotment option. |
F-
STATEMENTS OF OPERATIONS
| For the Year Ended December 31, 2025 | For the Period from July 24, 2024 (Inception) Through December 31, 2024 | |
|---|---|---|
| Operating costs | $802,565 | $146,618 |
| Loss from operations | (802,565) | (146,618) |
| Other income (expense): | ||
| Change on fair value of over-allotment option liability | (446) | 10,666 |
| Interest earned on marketable securities held in Trust Account | 4,838,462 | 96,478 |
| Total other income, net | 4,838,016 | 107,144 |
| Net income (loss) | $4,035,451 | $(39,474) |
| Weighted average redeemable shares outstanding | 11,491,781 | 634,921 |
| Basic and diluted net income (loss) per redeemable ordinary share | $0.25 | $(0.01) |
| Weighted average non-redeemable shares outstanding | 4,537,295 | 4,385,714 |
| Basic and diluted net income (loss) per non-redeemable ordinary share | $0.25 | $(0.01) |
F-
STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
FOR THE YEAR ENDED DECEMBER 31, 2025 AND
FOR THE PERIOD FROM JULY 24, 2024 (INCEPTION) THROUGH DECEMBER 31, 2024
| Ordinary Shares · Stock Subscription Receivable from Shareholders · Additional Paid-in Capital · Accumulated Deficit · Total Shareholders’ Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| Balance — July 24, 2024 (Inception) | — | $— | $— | $— | $— | $— |
| Ordinary shares issued to Sponsor (1)(2) | 3,833,333 | 383 | (25,000) | 24,617 | — | — |
| Ordinary shares issued to underwriter (2) | 266,667 | 27 | — | 1,538,373 | — | 1,538,400 |
| Sale of 400,000 Private Placement Units | 400,000 | 400 | 3,999,960 | 4,000,000 | ||
| Fair value of rights included in Public Units | 1,379,000 | 1,379,000 | ||||
| Allocated value of transaction costs to redeemable shares | (137,841) | (137,841) | ||||
| Accretion for redeemable ordinary shares to redemption amount | (5,918,545) | (5,918,545) | ||||
| Collection of stock subscription receivable from shareholder | — | 25,000 | — | — | 25,000 | |
| Net loss | — | — | — | — | (39,474) | (39,474) |
| Balance – December 31, 2024 | 4,500,000 | 450 | — | 885,564 | (39,474) | 846,540 |
| Sale of 37,500 Private Placement Units | 37,500 | 4 | — | 374,996 | — | 375,000 |
| Fair value of rights included in Public Units | 206,850 | 206,850 | ||||
| Fair value of over-allotment exercised | 148,416 | 148,416 | ||||
| Allocated value of transaction costs to Public Rights | — | — | (3,878) | — | (3,878) | |
| Remeasurement of carrying value to redemption value | — | — | (1,611,948) | (3,785,736) | (5,397,684) | |
| Net income | — | — | — | — | 4,035,451 | 4,035,451 |
| Balance – December 31, 2025 | 4,537,500 | $454 | $— | $— | $210,241 | $210,695 |
The accompanying notes are an integral part of these financial s
tate
ments.
F-
STATEMENTS OF CASH FLOWS
| For the Year Ended December 31, 2025 | For The Period from July 24, 2024 (Inception) Through December 31, 2024 | |
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | $4,035,451 | $(39,474) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Interest earned on marketable securities held in Trust Account | (4,838,462) | (96,478) |
| Change in Fair Value of Overallotment liability | 446 | (10,666) |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | 124,779 | (228,774) |
| Accounts payable and accrued expenses | 90,505 | 41,117 |
| Net cash used in operating activities | (587,281) | (334,275) |
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | (15,075,000) | (100,500,000) |
| Net cash used in investing activities | (15,075,000) | (100,500,000) |
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | 14,718,750 | 98,125,000 |
| Proceeds from sale of Private Placement Units | 375,000 | 4,000,000 |
| Proceeds from share subscription receivable from shareholder | — | 25,000 |
| Proceeds from Issuance of Representative shares | — | 2,319 |
| Proceeds from promissory note - related party | — | 322,720 |
| Repayment of promissory note - related party | — | (322,720) |
| Payment of offering costs | — | (436,191) |
| Net cash provided by financing activities | 15,093,750 | 101,716,128 |
| Net Change in Cash | (568,531) | 881,853 |
| Cash – Beginning of period | 881,853 | — |
| Cash – End of period | $313,322 | $881,853 |
| Non-Cash investing and financing activities: | ||
| Remeasurement of carrying value to redemption value | $5,397,684 | $5,918,545 |
| Deferred offering costs included in accrued offering costs | $— | $75,000 |
| Deferred offering costs paid by Sponsor in exchange for issuance of non-redeemable ordinary shares | $— | $383 |
F-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.